News from NORD

NIH Workshop Focuses on Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

Publish date: May 10, 2017

 

NIH recently hosted a workshop to bring researchers together to discuss severe drug reactions such as Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis and possible genetic factors that might predispose individuals to greater risk.

Recommended Reading

DTC genetic health risk tests: Beware
MDedge Family Medicine
VIDEO: Big research trials at AAN bring up important cost decisions
MDedge Family Medicine
VIDEO: Cannabidiol reduces convulsive seizures in Dravet syndrome
MDedge Family Medicine
For girls with Turner syndrome, experimental fertility preservation may offer the hope of a baby of their own
MDedge Family Medicine
Cannabidiol cuts drop seizure frequency in Lennox-Gastaut syndrome
MDedge Family Medicine
VIDEO: About 1 in 20 ALS patients in Washington state chose assisted suicide
MDedge Family Medicine
Cushing’s appears to begin its cardiovascular effects during childhood
MDedge Family Medicine
Patient Advocacy Groups Oppose AHCA
MDedge Family Medicine
NORD Issues RFPs for 2017 Research Grants for Study of Rare Diseases
MDedge Family Medicine
NORD Rare Action Network Issues Spring 2017 State Policy Legislative Tracker
MDedge Family Medicine